Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

makes restored skin flexibility appear to promote abnormal cell spread

Restoring tissue flexibility may improve mechanics without increasing abnormal cell growth or . The hypothesis predicts that apparent spread disappears when imaging follows , counts , and tracks actual .

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

The hypothesis does not specify a biological function

Direction

Lens

Puts the cause in the measurement rather than the biology: the instrument, or the definition of what is being counted, produces the result.Measurement and interpretation

A double ring marks the main placement where a group contains several values.

Goal
Repair-Phase Miscoordination and Repeated-Renewal Selection Restraint
Competing hypotheses
2
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
10 / 10Clarity of mechanism
10 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Way of recording

    size measurement

    A measurement of size using projected area or

    Where this hypothesis actsIn tissue deformed by loading after restoration

    Hypotheses on this target 1
    Clone size measurementTelling states apart. Hypotheses on this target 11Direct measurement. Hypotheses on this target 0Indicator replacement. Hypotheses on this target 0
    • Telling states apart1
    • Direct measurement
    • Indicator replacement

    What is proposed

    Telling states apart

    Distinguish actual growth from deformation-induced increases in projected area

    With whatInstrument or assay

    HowUse , , , and

    Possible result

    Expected disappearance of the apparent increase in size after accounting for

    From the recordThe compliance-associated rise in projected clone area and apparent invasion depth disappears when measurements use tissue-following three-dimensional registration, absolute lineage-labeled cell counts, and crossing of the continuously tracked basement-membrane surface.

  2. Indicator or biomarker

    measurement

    An assessment of cell based on apparent depth or actual crossing of the

    Where this hypothesis actsAt the displaced or folded under after restoration

    Hypotheses on this target 1
    Invasion measurementTelling states apart. Hypotheses on this target 11Direct measurement. Hypotheses on this target 0Indicator replacement. Hypotheses on this target 0
    • Telling states apart1
    • Direct measurement
    • Indicator replacement

    What is proposed

    Telling states apart

    Distinguish actual from displacement below a

    With whatInstrument or assay

    HowUse with and labeled to continuously track its surface, with and

    Possible result

    Expected disappearance of apparent when displacement is distinguished from

    From the recordSofter tissue stretches laterally and folds or displaces the basement membrane under shear, increasing projected clone area and moving intact basal cells below a fixed reference plane.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burdenClone size measurement. Hypotheses on this target 1Clone size measurementInvasion measurement. Hypotheses on this target 1Invasion measurement

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Making aging skin more flexible could change both how it works and how abnormal cell growth appears under a microscope. The unexpected move is to propose that stretching and folding create an apparent cancer risk without additional growth or . That explanation was generated by the pipeline; the supplied material does not establish it as a measured result.

The proposed mechanism, link by link
  1. Restored flexibility allows skin to stretch sideways and fold under forces that slide tissue layers relative to one another.
  2. Sideways stretching enlarges a cell group's area in a flat image without increasing its cell count.
  3. Folding or displacement moves the and its attached cells below a fixed image reference level without cells crossing the membrane.
  4. Rebuilding attachments in stages reduces tissue distortion, making abnormal spread appear reduced without changing cell reproduction or actual membrane crossing.
A picture for it

A patch drawn on a stretchy sheet looks wider when the sheet is pulled, and a fold can carry part of it below the tabletop without anything passing through the sheet.

Where the picture breaks: Living cells can reproduce and cross their supporting layer. The sheet illustrates how movement could mislead a measurement, but cannot establish that biological growth or is absent.

  1. Master questionstep 01 of 04

    Aging human skin might be brought into a lasting, youthful working state through a minimal combination of changes to cells, their surrounding support material, the places that maintain replacement cells, blood vessels, and nerves.

    Rests on: The stated goal is to identify changes that are both necessary and sufficient together to achieve and maintain that state; its feasibility remains a question.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Mistimed repair and limits on which cells gain an advantage during repeated renewal are named as a focus.

    Rests on: The master question includes lasting changes in cells and their surroundings, but does not identify repair timing or repeated renewal as the route to achieving them.

    Leap

    Only a title is supplied. No explanation connects this focus to the changes necessary and sufficient for lasting youthful skin function.

  3. Gap questionstep 03 of 04

    Restoring flexibility where tissue layers meet might improve replacement and resistance to repeated mechanical stress while freeing abnormal cell groups from surrounding structural restraint. Rebuilding their attachments in stages is proposed as a way to separate those effects.

    Rests on: The preceding title identifies repair coordination and restraint during renewal, but supplies no account of tissue flexibility or attachment reconstruction.

    Leap

    The chain supplies no connecting explanation for why flexibility would improve renewal while releasing abnormal cells, or why rebuilding attachments in stages would separate those outcomes.

  4. Hypothesisstep 04 of 04

    Softer skin is proposed to stretch and fold so that an abnormal , a group of cells descended from one cell, looks larger without gaining cells. Movement of the , the thin supporting layer beneath the skin's bottom cell layer, could also make cells look invasive without their crossing that layer. Rebuilding attachments in stages is proposed to reduce these misleading movements.

    Rests on: The preceding question supplies the contrast between mechanical improvement and apparent abnormal spread. The endpoint supplies its own proposed explanation: tissue movement changes image measurements, and stronger attachments reduce that movement.

    Stated in the chain

What is carried, and what is not. The supplied screened source establishes none of the four proposed mechanism links. The 2023 Nature study reports a discontinuity in the supporting layer at the advancing edge of invading cell groups in mouse ear skin, challenging a blanket movement-only explanation of ; it does not test restored flexibility, staged attachment reconstruction, or image distortion, and does not establish this proposed sequence end to end.

Where the reasoning is carried by something unstated · 2
  • Goal pillar. Only a title is supplied. No explanation connects this focus to the changes necessary and sufficient for lasting youthful skin function. Establish the missing link before relying on this step.
  • Gap question. The chain supplies no connecting explanation for why flexibility would improve renewal while releasing abnormal cells, or why rebuilding attachments in stages would separate those outcomes. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A larger flat image or a cell below a fixed reference level could be counted as growth or even though only tissue position changed. What closes it: The specified measurements must follow tissue landmarks in three dimensions, count cells carrying inherited identifying labels, and determine crossing relative to the continuously tracked .
  • An immediate reduction in apparent spread after removing force could be read as evidence that all of the effect was geometric, even if lasting cell growth or genuine crossing also occurred. What closes it: Cell counts and actual membrane crossings must be assessed alongside the reversible image change. The supplied design does not specify the follow-up duration, so it does not establish how long persistent growth would be sought.
  • Reproducing the appearance in preserved, nonliving tissue could be taken to prove that movement fully explains the living-tissue result. What closes it: The , tissue preserved so it no longer grows or responds, must undergo comparable deformation. It establishes that geometry can produce the appearance; living-tissue counts and tracked crossings must separately establish whether biological progression also occurs.

What would make this wrong. Actual or persistent increases in cell number after force is removed, despite measurements that follow tissue movement, would reject movement alone as the explanation. The supplied hypothesis also identifies rejection by interventions that reverse genuine biological progression through either rival route: communication between cells that ends repair, or growth signaling through a cell's small surface projection.

What it would change. If this held, some apparent costs of restoring skin flexibility would be measurement effects, and evaluating lasting skin repair would require separating tissue movement from cell growth and . An apparent safety benefit from staged attachment reconstruction would not by itself establish better control of abnormal cells. Even then, the minimal changes sufficient for stable youthful function in aging human skin would remain unknown, as would whether the explanation applies across tissues and over long periods.

Sources read · 1

6 literature searches, 10 full texts; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Contradicts it

The extracellular matrix dictates regional competence for tumour initiation. · Nature · 2023

“immunostaining components of the basal lamina (α6-integrin and Laminin-332) and electron microscopy analysis showed that there is a discontinuity of the basal lamina at the leading edge of invading SmoM2 clones in the ear”

Does not settle: This source does not test compliance restoration, staged anchoring, imaging-coordinate deformation, or whether those interventions could alter projected clone area without changing biological invasion.

The gap this hypothesis explains

Can making skin interfaces more flexible improve renewal and durability without freeing abnormal cells to expand, through staged reattachment?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Can restoring interface improve renewal and while removing on abnormal , and can separate these opposing effects?

What this question is asking

The question concerns whether changing how readily the boundaries between skin structures give way under force could improve aging human skin without weakening control over abnormal cells. It asks whether restoring interface would improve cell replacement and resistance to damage from repeated loading, while also reducing restraint imposed by the on abnormal . It then asks whether rebuilding the attachments between skin structures in successive steps could retain the benefits while preventing that loss of restraint. The comparison is between flexibility restoration alone and restoration combined with staged rebuilding of attachments, measuring both skin function and abnormal-cell behavior. The question assumes that greater flexibility could produce these opposing effects, but the supplied evidence establishes only a narrower example of changes permitting abnormal growth.

What the terms mean
Interface compliance
How readily a boundary between structures deforms when force is applied. varies continuously; the input does not identify the exact skin boundary or a target level of flexibility.
Renewal
Replacement of cells and maintenance of tissue over time. The input does not specify how renewal would be measured or what would count as an improvement.
Fatigue resistance
The ability to resist damage from repeated physical loading. An improvement in a material's mechanical properties does not by itself establish improved .
Extracellular matrix
The material outside cells that provides structural support and influences cell behavior. In this question, its possible roles in supporting normal skin function and restricting abnormal growth create the proposed tension.
Matrix restraint
Limits that the material surrounding cells places on abnormal growth or . The question uses this as a functional description, rather than specifying a single restraining structure or mechanism.
Abnormal clone
A group of cells descended from one cell and sharing an abnormal characteristic. The input does not specify which abnormalities or groups of cells the proposed skin intervention would affect.
Staged anchoring reconstruction
Rebuilding attachments between skin structures in successive steps. The input supplies no defined procedure, timing or sequence, so the phrase names a proposed approach rather than an established treatment.
Basement membrane
A specialized layer of extracellular support material at a tissue boundary. S6 concerns adding its proteins at the boundary between the outer and deeper skin layers.
Tissue remodeling
Changes to the composition and organization of tissue. Such rebuilding is not by itself evidence of restored youthful function.
Collagen bundles
Grouped fibers of a structural protein in the . S10 concerns reducing their abundance and thickness while preserving their direction of alignment.
Dermis
The deeper skin layer beneath the outer covering. It is the layer invaded by the abnormal growths reported in S10.
Cancer-driving alteration
A cellular change that promotes cancerous growth. S10 concerns one particular alteration, so its result does not establish how every kind of abnormal cell would respond.
What the question takes for granted
Premise only partly supported
Restoring interface can improve renewal and while removing on abnormal , creating opposing effects that might separate.

The assumption concerns the flexibility of boundaries within skin and the surrounding material that supports cells and influences their behavior. It proposes that making those boundaries more flexible could improve cell replacement and resistance to repeated physical stress, but also loosen limits on groups of abnormal cells. If both effects occurred, rebuilding the attachments between skin structures in stages would have a defined tradeoff to resolve.

S10 supports a narrower part of the premise: reducing collagen bundle abundance and thickness in mouse back skin permitted cancer-driving changes to produce growths that invaded the deeper skin layer. It does not establish that restoring interface is equivalent to that collagen reduction. S1 reports improved properties of an engineered support material, and S6 suggests that adding proteins at a skin-layer boundary supports attachment and tissue rebuilding; neither establishes the proposed renewal and fatigue benefits of flexibility restoration. No supplied source establishes that staged attachment rebuilding separates the proposed effects.S10S1S6

The same question asked without the part nothing read establishes:

  • Does restoring flexibility at interfaces in aging human skin change cell replacement, resistance to repeated loading, or abnormal-cell expansion?
  • Does rebuilding skin attachments in stages alter the functional and abnormal-cell effects of restoring interface flexibility in aging human skin?
What turns on the answer
  • Benefits and loss of restraint occur together If flexibility restoration improves cell replacement and resistance to repeated loading while releasing abnormal cells from , better skin function would coexist with increased abnormal growth. If staged attachment rebuilding does not separate those effects, the functional improvement would leave the proposed growth risk unresolved.
  • Staged rebuilding separates the effects If rebuilding attachments in stages retains improved renewal and resistance to repeated loading while preserving restraint on abnormal cells, the functional gains would no longer require the proposed loss of growth control. That outcome would support separation of this particular tradeoff, without establishing that all requirements for a stable youthful skin state had been met.
  • Benefits occur without loss of restraint If flexibility restoration improves skin function without releasing abnormal cells, the assumed conflict would not occur under those conditions. Staged attachment rebuilding would then have no demonstrated role in resolving that particular conflict.
  • The proposed functional benefits do not occur If flexibility restoration does not improve renewal or resistance to repeated loading, there would be no demonstrated functional benefit for staged rebuilding to preserve. Any accompanying loss of abnormal-cell restraint would then occur without the proposed compensating improvement.
Why it matters

The material surrounding skin cells provides physical support and also regulates cell attachment, multiplication and other activities, according to S4. Changing this material could therefore affect both how skin bears force and how its cells behave, although the supplied sources do not establish that both effects occur after the proposed intervention. If increased flexibility improved renewal but also allowed abnormal cells to expand, improved skin function alone would not establish a stable youthful state. If rebuilding attachments in stages preserved functional benefits while maintaining restraint, that would separate the two outcomes. Assuming either outcome without evidence could misidentify a functional improvement as safe and lasting, or dismiss a change whose proposed adverse effect has not been established.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

The apparent increase in spread or after restoration can arise from deformation of the rather than biological progression. Softer tissue stretches laterally and folds or displaces the under , increasing and moving intact below a fixed . reduces this geometric distortion, creating an apparent safety benefit without changing reproduction or actual . is real; its inferred cost is the .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

The -associated rise in and apparent disappears when measurements use , , and crossing of the continuously tracked . The apparent effect reverses immediately with and is reproduced in subjected to equivalent deformation. Genuine events, persistent growth after , or by or would reject this explanation.

Would tell it apart from at least one rival. The prediction specifies observable disappearance, reversal, and reproduction of the effect under stated conditions, plus explicit rejection conditions. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

with , labeled , , , and can directly separate displacement from growth and .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

The -associated rise in and apparent disappears when measurements use , , and crossing of the continuously tracked . The apparent effect reverses immediately with and is reproduced in subjected to equivalent deformation. Genuine events, persistent growth after , or by or would reject this explanation.

  • What would separate them

    Rebuilding skin anchorage can enable tumor initiation by restoring cellular signaling predicts: In aged human , at fixed increases , , , and subsequently verified , despite improved . abolishes the reconstruction-associated increase in without removing the mechanical benefit; restores it. Disrupting communication between surrounding does not determine this effect. Failure to detect the ordered -to--to- sequence, or persistence of the effect after validated , rejects this explanation.

  • What would separate them

    Skin cells restrain abnormal clones by relaying signals that end repair predicts: At , , , , and , spatially interrupting a small number of highly connected produces persistent and genuine , whereas interrupting the same number of does not. Restoring communication across the disconnected region suppresses these outcomes without changing . A must precede failed . If connectivity changes do not alter or despite verified disruption of , reject this hypothesis.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteA paper already fetched for this hypothesis bears on it

What it would take to refute it. 7 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Leader cell myosin 10 controls adhesion dynamics, invasion, and EMT pathway activation.; Systemic infection of tobacco mosaic virus is limited by upward transport and phloem unloading without coat protein.; Tumor cell Jagged-1 promotes regional lymphatic metastasis and predicts recurrence in node-positive breast cancer..

7 papers retrieved around this hypothesis
  • Leader cell myosin 10 controls adhesion dynamics, invasion, and EMT pathway activation.PMID 41943107 · full_text · 127,091 characters stored
  • Systemic infection of tobacco mosaic virus is limited by upward transport and phloem unloading without coat protein.PMID 42548270 · full_text · 69,628 characters stored
  • Spatial transcriptomics reveals clonal relationships between intraductal carcinoma and adjacent invasive prostate cancer.PMID 42236150 · full_text · 41,479 characters stored
  • The metastatic spectrum in functional and non-functional NENs: mechanistic insights from multi-omics.PMID 42724134 · full_text · 88,068 characters stored
  • Mitochondrial genome-derived microsatellites reveal genetic diversity and population structure in Callery pear populations.PMID 42752446 · full_text · 70,520 characters stored
  • Tumor cell Jagged-1 promotes regional lymphatic metastasis and predicts recurrence in node-positive breast cancer.PMID 42321861 · full_text · 105,693 characters stored
  • Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap.PMID 42746379 · full_text · 81,653 characters stored

0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.